Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Hippocampal myo-inositol and cognitive ability in adults with Down Syndrome

Hippocampal myo-inositol and cognitive ability in adults with Down Syndrome

Functional amyloid formation within mammalian tissue

Functional amyloid formation within mammalian tissue

Cerebrospinal fluid analysis combined with brain scan predicts Alzheimer's

Cerebrospinal fluid analysis combined with brain scan predicts Alzheimer's

Findings may help in development of new anti-inflammatory compounds

Findings may help in development of new anti-inflammatory compounds

Cole Porter was wrong - love only lasts a year!

Cole Porter was wrong - love only lasts a year!

Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia

Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia

Persistent amyloidosis following suppression of Ab production in a transgenic model of Alzheimer disease

Persistent amyloidosis following suppression of Ab production in a transgenic model of Alzheimer disease

Genetically modified allow scientists to examine the potential usefulness of new therapies for Alzheimer's disease

Genetically modified allow scientists to examine the potential usefulness of new therapies for Alzheimer's disease

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease

Study suggests that subtle breakdowns in attention may offer a reliable clue to Alzheimer's-related dementia

Study suggests that subtle breakdowns in attention may offer a reliable clue to Alzheimer's-related dementia

Link between diet and epileptic seizures studied

Link between diet and epileptic seizures studied

Lifelong exercise decreases cellular aging in the brain

Lifelong exercise decreases cellular aging in the brain

Those most at risk of Alzheimer's would allow loved ones enroll them in research

Those most at risk of Alzheimer's would allow loved ones enroll them in research

Should Alzheimer's sufferers take part in research?

Should Alzheimer's sufferers take part in research?

Resveratrol effective in lowering amyloid-beta peptides

Resveratrol effective in lowering amyloid-beta peptides

Protein alpha-synuclein associated with causing neurodegenerative conditions may actually protects against neurodegeneration

Protein alpha-synuclein associated with causing neurodegenerative conditions may actually protects against neurodegeneration

Scientists find new mechanism by which brain cells can be damaged during chronic neurodegenerative diseases

Scientists find new mechanism by which brain cells can be damaged during chronic neurodegenerative diseases

Protein called CHIP helps untangle protein misfolding in brain disease

Protein called CHIP helps untangle protein misfolding in brain disease

iNOS inhibitors may be effective therapies for Alzheimer's disease

iNOS inhibitors may be effective therapies for Alzheimer's disease

HapMap will give clues to many common diseases

HapMap will give clues to many common diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.